PNC Financial Services Group
SLS icon

PNC Financial Services Group’s SELLAS Life Sciences SLS Stock Holding History

PNC Financial Services Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$35.6K Buy
2,890
+256
+10% +$3.21K ﹤0.01% 3582
2026
Q2 		$38.9K Buy
2,634
+2,345
+811% +$16.2K ﹤0.01% 3479
2026
Q1 		$1.22K Buy
289
+6
+2% +$27 ﹤0.01% 4707
2025
Q4 		$1.07K Sell
283
-869
-75% -$1.69K ﹤0.01% 4679
2025
Q3 		$1.86K Buy
+1,152
New +$2.05K ﹤0.01% 4520
2022
Q1 		– Sell
-704
Closed -$4K – 4689
2021
Q4 		$4K Hold
704
– – ﹤0.01% 4034
2021
Q3 		$6K Hold
704
– – ﹤0.01% 3896
2021
Q2 		$8K Hold
704
– – ﹤0.01% 3773
2021
Q1 		$6K Hold
704
– – ﹤0.01% 3784
2020
Q4 		$4K Buy
+704
New +$2.82K ﹤0.01% 3764
2019
Q4 		– Sell
-1
Closed – – 4093
2019
Q3 		$0 Buy
+1
New +$7 ﹤0.01% 4096

Other funds holding SLS

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

PNC Financial Services Group's SLS Position: Q3 2026 in Review

PNC Financial Services Group increased its SELLAS Life Sciences (SLS) stake by 9.7% in Q3 2026, buying an estimated $3.21K and bringing the position to 2,890 shares worth $35.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3582.

PNC Financial Services Group first reported a position in SLS in Q3 2019 and has held it in 11 quarters since. The position peaked at $38.9K in Q2 2026. 168 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • PNC Financial Services Group held 2,890 shares of SELLAS Life Sciences worth $35.6K as of Q3 2026.
  • PNC Financial Services Group bought 256 SELLAS Life Sciences shares in Q3 2026, an estimated $3.21K.
  • SELLAS Life Sciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3582 holding.
  • PNC Financial Services Group first reported a position in SELLAS Life Sciences in Q3 2019 and has held it in 11 quarters since.
  • PNC Financial Services Group's SELLAS Life Sciences position peaked at $38.9K in Q2 2026.
  • 168 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.